Pursuant to Article 23 of Code on Public Health and Healthcare System of the Republic of Kazakhstan No. 360-VI dated July 7, 2020, all pharmaceutical products, whether manufactured in Kazakhstan or imported from abroad, are subject to mandatory state registration. Without state registration, manufacturing, importation, and sale of pharmaceutical products are prohibited.
Consequences of Non-Compliance:
Violation of the prohibition on the sale of unregistered pharmaceutical products may result in administrative liability, including fines and suspension of business activities.
If such a violation results in harm to human health, more severe sanctions may apply. These measures are also provided for under administrative legislation but involve significantly stricter penalties.
LEGAL FRAMEWORK